Federico Gaiti

16PUBLICATIONS
91CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer cell biologyHaematologyCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 20, 2026
IFNγ Drives Long-Term Bone Marrow Niche Dysfunction Following Doxorubicin-Based Chemotherapy.

|Dec 15, 2025
Methylation-based lineage tracing in cancer.

Jiaoyi Chen, Benson Z Wu, Federico Gaiti

|Dec 02, 2025
Reflections on Advances in Cancer Research in 2025.

Elsa Bernard, Isidro Cortés-Ciriano, Federico Gaiti

|Apr 16, 2025
Metformin reduces the competitive advantage of Dnmt3aR878H HSPCs.

Mohsen Hosseini, Veronique Voisin, Ali Chegini

|Dec 31, 2024
Molecular correlates for HPV-negative head and neck cancer engraftment prognosticate patient outcomes.

Matthew Waas, Christina Karamboulas, Benson Z Wu

|Feb 26, 2024
Metformin reduces the clonal fitness of Dnmt3a R878H hematopoietic stem and progenitor cells by reversing their aberrant metabolic and epigenetic state.

Mohsen Hosseini, Veronique Voisin, Ali Chegini

Pageof 3

Frequent Collaborators

4 joint publications

Ronan Chaligne

4 joint publications

Dan A Landau

3 joint publications

Miloš Tanurdžić

2 joint publications

Bernard M Degnan